Genetic polymorphisms in vitamin D metabolism and signaling genes and risk of breast cancer: A nested case-control study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Clendenen, Tess V ^a   Ge, Wenzhen ^a   Koenig, Karen L ^a   Axelsson, Tomas ^b   Liu, Mengling ^a   Afanasyeva, Yelena ^a   Andersson, Anne ^c   Arslan, Alan A ^a   Chen, Yu ^a   Hallmans, Göran ^d   Lenner, Per ^c   Kirchhoff, Tomas ^a   Lundin, Eva ^d   Shore, Roy E ^a,e   Sund, Malin ^c   Zeleniuch Jacquotte, Anne ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL 24 HYDROXYLASE; ESTROGEN RECEPTOR; RETINOID X RECEPTOR ALPHA; VITAMIN D; 7-DEHYDROCHOLESTEROL REDUCTASE; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP24A1 PROTEIN, HUMAN; CYP27B1 PROTEIN, HUMAN; CYP2R1 PROTEIN, HUMAN; CYTOCHROME P450 FAMILY 2; HYDROXYCOLECALCIFEROL; OXIDOREDUCTASE; VITAMIN D BINDING PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DHCR7 GENE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; NULLIPARA; ONCOGENE; POSTMENOPAUSE; RXRA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; VDBP GENE; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; AGED; BLOOD; BREAST TUMOR; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SWEDEN;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHOLESTANETRIOL 26-MONOOXYGENASE; COHORT STUDIES; CYTOCHROME P450 FAMILY 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYDROXYCHOLECALCIFEROLS; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; RETINOID X RECEPTOR ALPHA; SIGNAL TRANSDUCTION; SWEDEN; VITAMIN D-BINDING PROTEIN; VITAMIN D3 24-HYDROXYLASE;

EID: 84949494365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140478     Document Type: Article

References (34)

1. Welsh J. Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys. 2012; 523(1):107-14. Epub 2011/11/17. PMID: 22085499; PubMed Central PMCID: PMC3295909. doi: 10.1016/j.abb.2011.10.019
2. Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, et al. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res. 2013; 15 (1):R15. Epub 2013/02/28. PMID: 23442740; PubMed Central PMCID: PMC3672761. doi: 10.1186/bcr3390
3. Kim Y, Je Y. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer. 2014; 110(11):2772-84. Epub 2014/04/10. PMID: 24714744; PubMed Central PMCID: PMC4037823. doi: 10.1038/bjc.2014.175
4. Wang D, Velez de-la-Paz OI, Zhai JX, Liu DW. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Tumour Biol. 2013. Epub 2013/06/29. PMID: 23807676. doi: 10.1007/s13277-013-0929-2
5. Kuhn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, Kvaskoff M, et al. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int J Cancer. 2013; 133(7):1689-700. Epub 2013/03/26. PMID: 23526380. doi: 10.1002/ijc.28172
6. Visvanathan K, Mondul A, Zeleniuch-Jacquotte A, Mukhtar TK, Smith-Warner SA, Ziegler RG. Abstract P3-07-01: Circulating vitamin D concentrations and breast cancer risk: A pooled analysis of 17 cohorts. Cancer Research. 2015; 75(9 Supplement):P3-07-1.
7. Zhu JG, Ochalek JT, Kaufmann M, Jones G, Deluca HF. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci U S A. 2013; 110(39):15650-5. Epub 2013/09/11. PMID: 24019477. doi: 10.1073/pnas.1315006110
8. Kemmis CM, Salvador SM, Smith KM, Welsh J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3. J Nutr. 2006; 136(4):887-92. Epub 2006/03/22. PMID: 16549446.
9. Segersten U, Holm PK, Bjorklund P, Hessman O, Nordgren H, Binderup L, et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Breast Cancer Res. 2005; 7(6):R980-6. Epub 2005/11/11. PMID: 16280049; PubMed Central PMCID: PMC1410765.
10. Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012; 523(1):9-18. Epub 2011/11/22. PMID: 22100522. doi: 10.1016/j.abb.2011.11.003
11. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63(4):954-9. Epub 1986/10/01. PMID: 3745408.
12. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985; 61(5):969-75. Epub 1985/11/01. PMID: 3840175.
13. Bishop JE, Collins ED, Okamura WH, Norman AW. Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs. J Bone Miner Res. 1994; 9(8):1277-88. Epub 1994/08/01. PMID: 7976510.
14. Wang J, He Q, Shao YG, Ji M, Bao W. Associations between vitamin D receptor polymorphisms and breast cancer risk. Tumour Biol. 2013. Epub 2013/08/01. PMID: 23900677. doi: 10.1007/s13277-013-0967-9
15. Tang C, Chen N, Wu M, Yuan H, Du Y. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009; 117(2):391-9. Epub 2009/01/16. PMID: 19145484. doi: 10.1007/s10549-008-0262-4
16. Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009; 30(7):1170-80. Epub 2009/05/01. PMID: 19403841. doi: 10.1093/carcin/bgp103
17. Gnagnarella P, Pasquali E, Serrano D, Raimondi S, Disalvatore D, Gandini S. Vitamin D receptor polymorphism FokI and cancer risk: A comprehensive meta-analysis. Carcinogenesis. 2014. doi: 10.1093/carcin/bgu150 PMID: 25053622
18. Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, et al. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control. 2015; 26(2):187-203. PMID: 25421379; PubMed Central PMCID: PMC4302042. doi: 10.1007/s10552-014-0497-9
19. Mondul AM, Shui IM, Yu K, Weinstein SJ, Tsilidis KK, Joshi AD, et al. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2015; 24(3):627-30. PMID: 25542828; PubMed Central PMCID: PMC4355227. doi: 10.1158/1055-9965.EPI-14-1127
20. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res. 2007; 9(1):R9. Epub 2007/01/25. PMID: 17244366; PubMed Central PMCID: PMC1851389.
21. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev. 2008; 17(6):1339-43. Epub 2008/06/19. PMID: 18559548. doi: 10.1158/1055-9965.EPI-08-0162
22. Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev. 2011; 20(8):1708-17. Epub 2011/06/23. PMID: 21693626. doi: 10.1158/1055-9965. EPI-11-0300
23. Fuhrman BJ, Freedman DM, Bhatti P, Doody MM, Fu YP, Chang SC, et al. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res. 2013; 33(2):543-51. Epub 2013/02/09. PMID: 23393347.
24. Dorjgochoo T, Delahanty R, LuW, Long J, Cai Q, Zheng Y, et al. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev. 2011; 20(10):2313-6. Epub 2011/08/11. PMID: 21828234; PubMed Central PMCID: PMC3189282. doi: 10.1158/1055-9965.EPI-11-0704
25. Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, et al. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res. 2012; 14(2):R58. Epub 2012/04/07. PMID: 22480149; PubMed Central PMCID: PMC3446393.
26. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010; 376(9736):180-8. Epub 2010/06/15. PMID: 20541252; PubMed Central PMCID: PMC3086761. doi: 10.1016/S0140-6736(10)60588-0
27. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010; 19(13):2739-45. Epub 2010/04/27. PMID: 20418485; PubMed Central PMCID: PMC2883344. doi: 10.1093/hmg/ddq155
28. Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008; 93(9):3381-8. Epub 2008/07/03. PMID: 18593774; PubMed Central PMCID: PMC2567851. doi: 10.1210/jc.2007-2702
29. Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem. 2009; 42(10-11):1174-7. Epub 2009/03/24. PMID: 19302999. doi: 10.1016/j.clinbiochem.2009.03.008
30. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005; 77(1):15-22. Epub 2005/05/04. PMID: 15868280.
31. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr. 2009; 89(2):634-40. Epub 2009/01/01. PMID: 19116321. doi: 10.3945/ajcn.2008.26445
32. Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, Gunderson KL, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol. 2003; 68:69-78. Epub 2004/09/02. PMID: 15338605.
33. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Statistical Methods in Medical Research. 2007; 16(3):219-42. PMID: 17621469
34. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995; 57(1):289-300.